Zobrazeno 1 - 10
of 18
pro vyhledávání: '"L. Aljassem"'
Autor:
Hervé Dombret, Lionel Ades, S. de Botton, Norbert Vey, François Dreyfus, S. Raynaud, A. Stamatoullas, Sophie Park, Geneviève Leroux, Charikleia Kelaidi, Didier Bouscary, P. Lepelley, M. T. Daniel, Pierre Fenaux, L. Mannone, F. Picard, Sabine Brechignac, Stéphane Giraudier, L. Aljassem
Publikováno v:
Leukemia Research. 32:1049-1053
Anemia in MDS with 5q deletion was generally considered, until the advent of lenalidomide, unresponsive to available treatments. We analyzed erythroid response to erythropoetin (EPO) or darbepoetin (DAR) and thalidomide in MDS with 5q deletion treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be5e44eae76b702688eec3669edaa0a8
https://doi.org/10.1016/j.leukres.2007.11.037
https://doi.org/10.1016/j.leukres.2007.11.037
Autor:
M-P Gourin, François Dreyfus, J Delaunay, O. Beyne-Rauzy, Raphael Itzykson, C Ravoet, L. Aljassem, A. Ferrant, Norbert Vey, Lionel Ades, Pierre Fenaux, Rosa Sapena, V Coiteux, S. Cheze, A. Stamatoullas, B. Choufi, M Escoffre-barbe, Charikleia Kelaidi, Sophie Park, Emmanuel Raffoux
Publikováno v:
Leukemia. 27(6)
A large proportion of lower-risk myelodysplastic syndromes (MDS) respond to erythropoiesis-stimulating agents (ESA), but most responses are transient. We updated a previously reported cohort of lower-risk MDS patients treated with ESA and analyzed ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb781815d1f8f0d77b8f4ad950dd9791
https://pubmed.ncbi.nlm.nih.gov/23370672
https://pubmed.ncbi.nlm.nih.gov/23370672
Autor:
Marie-Thérèse Daniel, Keith Bourgeois, Lionel Mannone, Valérie Bardet, L. Aljassem, Stéphane Cheze, Beatrice Mahe, Charikleia Kelaidi, Lionel Ades, Sophie Park, Geneviève Leroux, Norbert Vey, Martine Escoffre-Barbe, Odile Beyne-Rauzy, Pascale Lepelley, Christophe Ravoet, Augustin Ferrant, Peter L. Greenberg, Hervé Dombret, François Dreyfus, Pierre Fenaux, Sophie Grabar, Aspasia Stamatoullas, Valérie Coiteux, Françoise Picard
Publikováno v:
Blood. 111(2)
We analyzed prognostic factors of response, response duration, and possible impact on survival of epoetin α, epoetin β, or darbepoetin α (DAR) with or without granulocyte colony-stimulating factor in 403 myelodysplastic syndrome (MDS) patients. Si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d86de04bb05b5653fdfa3bd6e0226ec9
https://pubmed.ncbi.nlm.nih.gov/17940203
https://pubmed.ncbi.nlm.nih.gov/17940203
Autor:
Richard Delarue, L. Aljassem, Charikleia Kelaidi, Pierre Fenaux, Thomas Prebet, Francois Dreyfus, Laurence Legros, Emmanuel Raffoux, Odile Beyne-Rauzy, S. Park, Rosa Sapena, Aspasia Stamatoullas, Jerome Tamburini, Valérie Coiteux, Laurence Sanhes
Publikováno v:
Leukemia Research. 33:S124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05fc7b7f00eebb4bcf17501b3b0b30b2
https://doi.org/10.1016/s0145-2126(09)70192-4
https://doi.org/10.1016/s0145-2126(09)70192-4
Autor:
Peter L. Greenberg, S. Park, Stéphane Cheze, Béatrice Mahé, Hervé Dombret, Valérie Coiteux, Pierre Fenaux, Sophie Grabar, Martine Escoffre-Barbe, Norbert Vey, Lionel Adès, K. Bourgeois, Marie-Thérèse Daniel, Odile Beyne-Rauzy, Christophe Ravoet, Pascale Lepelley, Augustin Ferrant, Geneviève Leroux, Francois Dreyfus, L. Aljassem, Charikleia Kelaidi, Françoise Picard, D. Vassilieff
Publikováno v:
Leukemia Research. 31:S113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ecf10a8049a4f2a0aa2d8294078a279
https://doi.org/10.1016/s0145-2126(07)70205-9
https://doi.org/10.1016/s0145-2126(07)70205-9
Autor:
Christophe Ravoet, Hervé Dombret, Valérie Coiteux, S. Park, Sophie Grabar, Francois Dreyfus, Françoise Picard, Pierre Fenaux, L. Aljassem, Marie-Thérèse Daniel, Norbert Vey, Lionel Adès, Béatrice Mahé, Augustin Ferrant, Stéphane Cheze, D. Vassilieff, Geneviève Leroux, Martine Escoffre-Barbe, Odile Beyne-Rauzy, Pascale Lepelley, Charikleia Kelaidi
Publikováno v:
Leukemia Research. 31:S93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77bd0aed5da021cf6450cfa0286dc7e6
https://doi.org/10.1016/s0145-2126(07)70169-8
https://doi.org/10.1016/s0145-2126(07)70169-8
Autor:
Norbert Vey, Stéphane de Botton, Aspasia Stamatoullas, Sabine Brechignac, Stéphane Giraudier, Hervé Dombret, Didier Bouscary, François Dreyfus, Sophie Park, L. Aljassem, Pascale Lepelley, Pierre Fenaux, Françoise Picard, Lionel Ades, Geneviève Leroux, Charikleia Kelaidi, Lionel Mannone, Beatrice Mahe, Marie-Thérèse Daniel
Publikováno v:
ResearcherID
Background: MDS with del 5q are characterized by profound anemia, which until the recent introduction of lenalidomide (N Engl J Med2005; 352: 549–57, J Clin Oncol2005;16S:5), was considered generally unresponsive to available treatments. In order t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22acc95ab93e5b75c7fe629644fb0c30
https://doi.org/10.1182/blood.v108.11.2678.2678
https://doi.org/10.1182/blood.v108.11.2678.2678
Autor:
Norbert Vey, Laurence Legros, Lionel Adès, Aspasia Stamatoullas, Augustin Ferrant, Hervé Dombret, Sophie Park, L. Aljassem, Charikleia Kelaidi, Stéphane Giraudier, Stéphane Cheze, Francois Dreyfus, V. Andrieux, Lionel Mannone, Sophie Grabar, Valérie Bardet, D. Vassilief, M.C. Quarre, Beatrice Mahe, Nicole Casadevall, Pierre Fenaux, Martine Escoffre-Barbe, Odile Beyne-Rauzy, S. de Botton, Christophe Ravoet
Publikováno v:
Blood. 108:522-522
Background: EPO and its derivative darbepoietin alfa (DAR) are important treatments of anemia in lower risk MDS. Prognostic factors of response and of its duration have been recently updated (Blood, 2005, 106, 803–11) and we reanalyzed them in a la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5061e3f003e301bc8053c0b93b1a0d93
https://doi.org/10.1182/blood.v108.11.522.522
https://doi.org/10.1182/blood.v108.11.522.522
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.